The Valencian Community transparently offers penetration data for biosimilar medicines, which reach a market share of 45 percent. This was revealed in the drafting meeting 'Biosimilar Medicines. Access routes to innovation in C. Valenciana', sponsored by BioSim.
recently published
VI National Conference on Biosimilars
November 21 2024
Infographics published during Global Biosimilars Week 2024
November 15 2024
Biocon Biologics joins BioSim as a new member
October 30 2024
